Patients with higher BMI were more likely than patients with lower BMI to undergo recommended assays for HbA1c, nephropathy and lipid levels as well as retinal examinations, researchers reported in the American Journal of Managed Care. However, data showed higher-BMI patients were less likely to attain goals for blood glucose and blood pressure.

Related Summaries